107 related articles for article (PubMed ID: 3861325)
1. On the role of the spleen in Friend virus (F-MuLV-P) erythroleukemia.
Kreja L; Seidel HJ
Exp Hematol; 1985 Aug; 13(7):623-8. PubMed ID: 3861325
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
Sanfilippo F; Genovesi EV; Collins JJ
J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cells in Friend murine leukemia virus infected mice undergoing chemotherapy: failure to eradicate Ep-independent erythropoiesis by BCNU.
Seidel HJ; Kreja L
Exp Hematol; 1982 Feb; 10(2):151-60. PubMed ID: 7060665
[TBL] [Abstract][Full Text] [Related]
4. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effect of D-aspartic acid beta-hydroxamate (DAH) on Friend virus-infected erythropoietic progenitor cells.
Tournaire R; Arnaud S; Hamedi-Sangsari F; Malley S; Grange J; Blanchet JP; Doré JF; Vila J
Leukemia; 1994 Oct; 8(10):1703-7. PubMed ID: 7934166
[TBL] [Abstract][Full Text] [Related]
6. Friend erythroleukemia virus complex: role of viral components in modifying erythroid differentiation in mice.
Fagg B; Ostertag W
J Natl Cancer Inst; 1982 Mar; 68(3):457-60. PubMed ID: 6950173
[TBL] [Abstract][Full Text] [Related]
7. Role of BPA and erythropoietin for BFU-E growth from Friend virus-infected mice.
Kreja L; Seidel HJ
Stem Cells (1981); 1982; 1(6):367-80. PubMed ID: 7147094
[TBL] [Abstract][Full Text] [Related]
8. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice.
Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL
J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous regression of Friend murine leukemia virus-induced erythroleukemia. IV. Effects of radiation and athymia on leukemia regression in mice.
Furmanski P; Dietz M; Fouchey S; Hall L; Clymer R; Rich MA
J Natl Cancer Inst; 1979 Aug; 63(2):449-54. PubMed ID: 287833
[TBL] [Abstract][Full Text] [Related]
10. Effects of tacrolimus on infection of Friend murine leukemia virus to Fv-4 gene heterozygous mice.
Zhang FM; Yang BF; Gu HX; Chen XB; Zhong ZH; Cheng Z
Acta Pharmacol Sin; 2004 Feb; 25(2):208-12. PubMed ID: 14769211
[TBL] [Abstract][Full Text] [Related]
11. Expression of Friend leukemia virus and spleen focus-forming virus-specific sequences in erythroid bursts and granulocyte-macrophage colonies from spleen and marrow of mice infected with Friend leukemia virus.
Colletta G; Di Fiore PP; Fusco A; Lettieri F; Covelli A; Peschle C
Cancer Res; 1983 Feb; 43(2):598-603. PubMed ID: 6293700
[TBL] [Abstract][Full Text] [Related]
12. A radiosensitive T-lymphocyte associated with resistance of DBA/2 mice harboring Friend leukemia virus-dormant infections to transplantable Friend leukemia virus-erythroleukemia cells.
DiCicco LM; Truitt GA; Wheelock EF
Cancer Res; 1986 Jan; 46(1):127-32. PubMed ID: 3509990
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Friend virus (FVP)-induced murine erythropoiesis with prostaglandin (PGF2 alpha): potentiation and inhibition of erythropoietin and prevention of both with PGD2.
Lewis JP; Moores RR; Neal WA; Garver FA; Lutcher CL; Zucali JR; Mirand EA
Exp Hematol; 1981 May; 9(5):540-9. PubMed ID: 6940758
[TBL] [Abstract][Full Text] [Related]
14. Friend viral pathogenesis in C57BL/6 reversible DBA/2 allophenic mice.
Dewey MJ; Eldridge PW
Exp Hematol; 1982 Oct; 10(9):723-31. PubMed ID: 7173342
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a Friend virus-replicating target cell.
Steinheider G; Seidel HJ; Kreja L
Exp Hematol; 1979 Oct; 7(9):443-51. PubMed ID: 527691
[TBL] [Abstract][Full Text] [Related]
16. Natural killer (NK) cells and interferon in Friend-virus-infected susceptible and resistant mice.
Hertenstein B; Kreja L; Seidel HJ
Exp Hematol; 1984 Aug; 12(7):603-9. PubMed ID: 6204881
[TBL] [Abstract][Full Text] [Related]
17. Erythroid cell fusion in the early phase of Friend virus leukemogenesis.
Behringer RR; LoCascio NJ; Dewey MJ
J Natl Cancer Inst; 1987 Sep; 79(3):601-3. PubMed ID: 3476795
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
[TBL] [Abstract][Full Text] [Related]
19. Normal and Friend virus specific cell compartments in Friend leukemia characterized by their sensitivity to actinomycin D in vivo.
Seidel HJ; Kreja L; Opitz U; Steinheider G; Eberle P
Blut; 1981 Nov; 43(5):287-96. PubMed ID: 6948584
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the early and late stages of myelomonocytic leukemia induced by Friend helper-independent virus F-MuLV: isolation and induction of Friend myelomonocytic leukemic cell lines.
Shibuya T; Mak TW
J Cell Physiol; 1983 Dec; 117(3):283-9. PubMed ID: 6581171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]